Evidence-Based Complementary and Alternative Medicine / 2016 / Article / Tab 2

Research Article

Effects of Shenfu Injection in the Treatment of Septic Shock Patients: A Multicenter, Controlled, Randomized, Open-Label Trial

Table 2

Clinical indexes during treatment.

ShenfuControls value

48 h
Blood glucose (mmol/L)9.01 ± 6.337.81 ± 3.070.134
PT (s)14.20 ± 3.6314.39 ± 7.510.858
APTT (s)37.28 ± 9.0036.76 ± 9.810.749
Fibrinogen (g/dL)3.76 ± 1.644.60 ± 6.120.304
BUN10.44 ± 7.869.28 ± 7.100.346
Cr101.16 ± 71.98104.94 ± 94.680.784
ALT78.51 ± 140.5654.96 ± 54.540.165
AST102.29 ± 161.0274.46 ± 91.010.235
WBC13.33 ± 9.6112.06 ± 10.220.422
RBC3.40 ± 0.683.75 ± 1.010.012
HCT30.66 ± 6.2831.71 ± 7.310.331
Platelets (×109/L)108.49 ± 75.42115.31 ± 81.190.585

48 h
CVP (cmH2O)10.67 ± 4.466.35 ± 3.160.018
ScvO279.63 ± 13.2854.70 ± 28.810.017

6 d
Arterial lactate (mmol/L)2.37 ± 2.812.60 ± 2.520.533
Lactate clearance−0.40 ± 0.59−0.33 ± 0.390.369

24 h
APACHE 214.75 ± 9.1315.14 ± 11.220.846

5 d
Urine output (mL/h)91.91 ± 49.97102.18 ± 40.250.274

6 d
Systolic pressure (mmHg)33.88 ± 19.4434.72 ± 25.970.851
Diastolic pressure (mmHg)15.46 ± 16.2513.12 ± 16.520.463
MAP (mmHg)21.60 ± 15.8220.32 ± 18.260.699
Heart rate (bpm)−24.51 ± 21.78−26.20 ± 26.740.719
Dose of dopamine (mg)842.04 ± 835.811224.71 ± 1704.240.237
Number of dopamine uses0.229
Dose of norepinephrine (mg)72.67 ± 64.1980.59 ± 137.680.759
Number of epinephrine uses0.99
ICU day (day) 9.4 ± 11.39.1 ± 14.40.895
Total hospital day (day)15.2 ± 13.714.1 ± 15.80.675

PT: prothrombin time; aPTT: activated partial prothrombin time; BUN: blood urea nitrogen; Cr: creatinine; ALT: alanine transaminase; AST: aspartate transaminase; WBC: white blood cells; RBC: red blood cells; HCT: hematocrit; CVP: central venous pressure; ScvO2: central venous oxygen saturation; APACHE: acute physiology and chronic health evaluation; ICU: intensive care unit.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.